Prolonged inhibition of intratumoral mast cells enhances efficacy of low-dose antiangiogenic therapy
{{output}}
Low-dose antiangiogenic therapies have demonstrated the ability to enhance normalization of tumor vessels, consequently improving hypoxia levels, drug delivery, and promoting anticancer immune responses. Mast cells have been identified as contributors to resis... ...
